Searcharxiv⌕ Search

arXiv subjects

Maria Chiara Martire

Publications and source records attributed to Maria Chiara Martire.

2 recordsLinked to original sources

Mixed Ion Beams Enable Simultaneous Treatment and Real-Time Imaging in Carbon Ion Therapy

Carbon ion therapy is one of the most advanced forms of radiotherapy, promising improved efficacy against resistant cancers. However, the high precision offered by the carbon ion Bragg peak requires precise knowledge of the beam range inside the patient. We report the first experimental realization of range monitoring and portal imaging with a mixed ion beam, where carbon ions are treating the tumor while helium ions simultaneously accelerated to the same velocity fully traverse the patient and provide treatment feedback. Using the GSI synchrotron, a beam of 12C3+ and 4He1+ ions is accelerated, exploiting their nearly identical charge-to-mass ratios. Stable extraction with controlled helium fractions down to 7% is demonstrated. Beam characterization reveals that the helium ion Bragg peak can be cleanly separated from the carbon ion fragment background which enables accurate detection of sub-millimeter Bragg peak displacements. Mixed-beam radiographs of a lung-cancer-like phantom offer target position detection to better than 0.5 mm accuracy. This establishes mixed beams as a powerful modality for real-time image guidance in carbon ion therapy, uniquely providing simultaneous treatment delivery, range probing, and portal imaging. By overcoming range uncertainty inside the patient, mixed beams will enable to fully exploit the precision of carbon ion therapy.

physics.med-ph↗

Dosimetric Study of Lung Modulation and Motion Effects in Carbon ion Therapy for Lung Cancer

Carbon-ion radiotherapy provides high dose conformity for lung cancer, but its benefit is limited by two sources of uncertainties: interplay between scanned beam delivery and tumor motion, and dose modulation from heterogeneous lung tissue. This study quantifies the separate and combined dosimetric impact of these effects using the GSI TRiP4D treatment planning system. Eighteen lung cancer 4DCT datasets from TCIA were analyzed. A modulation power ($P_{\mathrm{mod}}$) was assigned to lung voxels. Three values were sampled from a Gaussian distribution ($200μ\mathrm{m} \pm 67μ\mathrm{m}$), and an extreme value of $750μ\mathrm{m}$ was tested. Interplay doses were computed by combining scanned-beam delivery with patient-specific respiratory motion. Four scenarios were studied: static, static with modulation, interplay, and interplay with modulation. Metrics included $D95\%$, $V95\%$, homogeneity index (HI), lung $V16\mathrm{Gy}$, and heart $V20\mathrm{Gy}$. Interplay reduced target coverage by $5.2 \pm 1.5$ pp ($D95\%$), $12.1 \pm 5.9$ pp ($V95\%$), and $8.3 \pm 2.4$ pp (HI). Extreme $P_{\mathrm{mod}}$ alone caused small degradations. When combined with interplay, it partially compensated the loss. This effect decreased with 4D optimization. Fractionation mitigated interplay, leaving lung modulation as the main residual effect.

physics.med-ph↗